CXCL13 and neoplasm: Both in vitro and in vivo experiments confirmed the original hypothesis that the overexpression of CXCR5 improves the migration of CAR-T cells to the CXCL13-positive tumor site, as shown directly by tracking CAR-T cells in vivo.